Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Mahmood unveils refugee sponsorship route as asylum bill faces Labour test

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      World Cup: How brands will activate as the knockouts begin

      Morocco v Haiti: Group C - FIFA World Cup 2026

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Exclusive: Richard Caring in talks to buy City icon 1 Lombard Street

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper

Smith & Nephew

  • Smith & Nephew CEO to leave after salary spat, hitting share price

    October 21, 2019

    Medical device manufacturer Smith & Nephew’s chief executive has announced his departure “by mutual agreement” with the board amid reports he was unhappy with his pay. Namal Nawana will be replaced by former Roche Diagnostics chief Roland Diggelman after just 18 months in the role, sending shares tumbling eight per cent to 1,683p. Read more: [...]

  • Smith & Nephew share price tilts south as medical giant pulls hip device

    June 4, 2015

    Medical device manufacturer Smith & Nephew was forced to announce its plans to withdraw one of its hip-replacement systems as it required too many post-operative follow-ups.    The 46mm model in question will be withdrawn from its Birmingham Hip Resurfacing system due to concerns it does not meet the standards set by health watchdog, Nice.  [...]

  • Smith & Nephew share price soars 8pc on Stryker takeover reports

    December 24, 2014

    Shares in medical equipment group Smith & Nephew surged eight per cent this morning, valuing the business at £10.4bn on the back of reports of a possible takeover by US group Stryker. Stryker, a US surgical implants manufacturer, denied it has any intention to buy the company back in May. However, Last month, it was [...]

  • Stryker deal talk boosts Smith & Nephew share price

    November 24, 2014

    US-based medical device company Stryker is reportedly examining the purchase of Smith & Nephew, the British manufacturer of surgical devices for orthopaedic construction. Yesterday Smith & Nephew’s stock jumped 4.4 per cent to 1,138p. The news came despite Stryker denying in May that it had any intention of making a bid for Smith & Nephew. [...]

  • US Zimmer deal boosts Smith & Nephew shares

    April 24, 2014

    SHARES in Smith & Nephew jumped over three per cent yesterday following the buy-out of a group that tried to buy the British health firm back in 2011. New York-listed Zimmer revealed that it is snapping up rival US orthopaedic company Biomet for $13.35bn (£7.95bn). The deal has added more weight to a widely-held view [...]

  • Smith & Nephew hit by rejection

    October 28, 2005

    Europe’s largest seller of orthopaedic devices saw its shares tumble to a two-year low after it abandoned producing a key leg ulcer treatment when America turned it down, but its sales are up. Smith & Nephew has abandoned production of a key leg ulcer treatment after it failed to win approval for the American market. [...]

Posts pagination

  • Previous
  • Page 1
  • Page 2

Trending Articles

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Burnham’s new chief of staff ran City firm advising Thames Water and rival Heathrow bidder

  • Barclays and Lloyds join banking sector plan for digital ID

  • Clarkson’s Farm and why businesses must stop blaming the weather

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited